Amy Schumer is coming clean about her weight loss drug journey. In an Instagram post she shared on March 21, she revealed she ...

I n addition to their origins as treatment for type 2 diabetes, GLP-1 receptor agonists like Ozempic and Wegovy are often ...

The 76-year-old Oscar winner got serious about her health following her diagnosis for type 2 diabetes in 2017, but there was ...

Oprah Winfrey jetted to Belgium to speak at the Supernova tech conference. The Queen of all media, 71, shared photos and ...

Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...

Gabby Thomas is sharing the hilariously relatable reason she’s not a fan of Ozempic. On March 21, the 28-year-old track star, ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

WSHU sits down with CT Mirror’s Katy Golvala to discuss her story about the debate over Medicaid coverage of weight loss ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

Month after claiming Ozempic left her 'bedridden', Amy Schumer revealed she's been using a different diabetes medication as a ...